• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.380 +0.140 (+2.67%)
Streaming Delayed Price Updated: 2:58 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 23, 2024
 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 23, 2024
Via ACCESSWIRE
News headline image
Why CNS Pharmaceuticals (CNSP) Stock Is Up 86% ↗
October 23, 2024
CNS Pharmaceuticals shares are trading higher by 76% Wednesday morning. The stock faces potential delisting for not meeting Nasdaq's $1.00 bid price. 
Via Benzinga
News headline image
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss ↗
October 23, 2024
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 23, 2024
 
Via Benzinga
News headline image
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
October 10, 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
October 08, 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via ACCESSWIRE
News headline image
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket ↗
October 23, 2024
 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Management, Dr. Samuel Goldlust Participate in Virtual Investor KOL Connect Segment
October 10, 2024
Via Investor Brand Network
Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment
October 04, 2024
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
September 23, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
August 22, 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 15, 2024
Via ACCESSWIRE
WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
September 13, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
September 12, 2024
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
September 03, 2024
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
August 27, 2024
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
August 22, 2024
Via Investor Brand Network
Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
August 21, 2024
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
August 15, 2024
Via Investor Brand Network
News headline image
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024 ↗
August 15, 2024
CNS Pharmaceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
August 06, 2024
 
Via Benzinga
Study Uncovers How Brain Tumors Evolve During Treatment
August 05, 2024
Via Investor Brand Network
News headline image
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
August 05, 2024
 
Via Benzinga
News headline image
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
July 30, 2024
 
Via Benzinga
News headline image
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue ↗
July 30, 2024
A Microsoft Office outage has workers annoyed as its causing problems with them being able to use the company's services. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap